Efficacy and safety of sirolimus in the treatment of gastrointestinal angiodysplasias

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 25

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastroenterol. Jul 7, 2025; 31(25): 105677
Published online Jul 7, 2025. doi: 10.3748/wjg.v31.i25.105677

Full Size Figure Download Figure

Figure 5 Sirolimus treatment for patients with gastrointestinal angiodysplasias. q.d.: Quaque die.

Citation: Sun Q, Wu JC, Chen X, Li DH, Li BR, Xiao NJ, Wang XY, Tu XZ, Ning SB, Sun T. Efficacy and safety of sirolimus in the treatment of gastrointestinal angiodysplasias. World J Gastroenterol 2025; 31(25): 105677
URL: https://www.wjgnet.com/1007-9327/full/v31/i25/105677.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i25.105677

Sun Q, Wu JC, Chen X, Li DH, Li BR, Xiao NJ, Wang XY, Tu XZ, Ning SB, Sun T. Efficacy and safety of sirolimus in the treatment of gastrointestinal angiodysplasias. World J Gastroenterol 2025; 31(25): 105677 [PMID: 40656607 DOI: 10.3748/wjg.v31.i25.105677]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.